Personal information

Other IDs

Scopus Author ID: 57202074978

Countries

Netherlands

Activities

Collapse all

Employment (2)

Erasmus MC: Rotterdam, Zuid-Holland, NL

2021-01-01 to present | Postdoctoral researcher (Immunology)
Employment
Source: Self-asserted source
Jamie van Langelaar

Erasmus MC: Rotterdam, Zuid-Holland, NL

2016-01-01 to 2021-03-16 | PhD Candidate (Immunology)
Employment
Source: Self-asserted source
Jamie van Langelaar

Education and qualifications (3)

University of Amsterdam: Amsterdam, Noord-Holland, NL

2013-09 to 2015-08 | Masters in Science, Brain and Cognitive Science: Behavioural Neuroscience
Education
Source: Self-asserted source
Jamie van Langelaar

University of South Africa: Pretoria, ZA

2013-01 to 2013-06 | Certificate, Project Management
Qualification
Source: Self-asserted source
Jamie van Langelaar

Stellenbosch University: Matieland, Western Cape, ZA

2010-01-01 to 2012-12 | Bachelors in Science, Molecular Biology and Biotechnology
Education
Source: Self-asserted source
Jamie van Langelaar

Works (42)

Data from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

2024-06-04 | Preprint
DOI: 10.1158/2326-6066.c.7267923.v1
Contributors: Michael V. Martin; Salvador Aguilar-Rosas; Katka Franke; Mark Pieterse; Jamie van Langelaar; Renée Schreurs; Maarten F. Bijlsma; Marc G. Besselink; Jan Koster; Wim Timens et al.
Source: check_circle
Crossref

Data from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

2024-06-04 | Preprint
DOI: 10.1158/2326-6066.c.7267923
Contributors: Michael V. Martin; Salvador Aguilar-Rosas; Katka Franke; Mark Pieterse; Jamie van Langelaar; Renée Schreurs; Maarten F. Bijlsma; Marc G. Besselink; Jan Koster; Wim Timens et al.
Source: check_circle
Crossref

Figure S1 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

2024-06-04 | Preprint
DOI: 10.1158/2326-6066.25964376.v1
Contributors: Michael V. Martin; Salvador Aguilar-Rosas; Katka Franke; Mark Pieterse; Jamie van Langelaar; Renée Schreurs; Maarten F. Bijlsma; Marc G. Besselink; Jan Koster; Wim Timens et al.
Source: check_circle
Crossref

Figure S1 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

2024-06-04 | Preprint
DOI: 10.1158/2326-6066.25964376
Contributors: Michael V. Martin; Salvador Aguilar-Rosas; Katka Franke; Mark Pieterse; Jamie van Langelaar; Renée Schreurs; Maarten F. Bijlsma; Marc G. Besselink; Jan Koster; Wim Timens et al.
Source: check_circle
Crossref

Figure S10 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

2024-06-04 | Preprint
DOI: 10.1158/2326-6066.25964373
Contributors: Michael V. Martin; Salvador Aguilar-Rosas; Katka Franke; Mark Pieterse; Jamie van Langelaar; Renée Schreurs; Maarten F. Bijlsma; Marc G. Besselink; Jan Koster; Wim Timens et al.
Source: check_circle
Crossref

Figure S10 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

2024-06-04 | Preprint
DOI: 10.1158/2326-6066.25964373.v1
Contributors: Michael V. Martin; Salvador Aguilar-Rosas; Katka Franke; Mark Pieterse; Jamie van Langelaar; Renée Schreurs; Maarten F. Bijlsma; Marc G. Besselink; Jan Koster; Wim Timens et al.
Source: check_circle
Crossref

Figure S11 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

2024-06-04 | Preprint
DOI: 10.1158/2326-6066.25964370
Contributors: Michael V. Martin; Salvador Aguilar-Rosas; Katka Franke; Mark Pieterse; Jamie van Langelaar; Renée Schreurs; Maarten F. Bijlsma; Marc G. Besselink; Jan Koster; Wim Timens et al.
Source: check_circle
Crossref

Figure S11 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

2024-06-04 | Preprint
DOI: 10.1158/2326-6066.25964370.v1
Contributors: Michael V. Martin; Salvador Aguilar-Rosas; Katka Franke; Mark Pieterse; Jamie van Langelaar; Renée Schreurs; Maarten F. Bijlsma; Marc G. Besselink; Jan Koster; Wim Timens et al.
Source: check_circle
Crossref

Figure S12 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

2024-06-04 | Preprint
DOI: 10.1158/2326-6066.25964367.v1
Contributors: Michael V. Martin; Salvador Aguilar-Rosas; Katka Franke; Mark Pieterse; Jamie van Langelaar; Renée Schreurs; Maarten F. Bijlsma; Marc G. Besselink; Jan Koster; Wim Timens et al.
Source: check_circle
Crossref

Figure S12 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

2024-06-04 | Preprint
DOI: 10.1158/2326-6066.25964367
Contributors: Michael V. Martin; Salvador Aguilar-Rosas; Katka Franke; Mark Pieterse; Jamie van Langelaar; Renée Schreurs; Maarten F. Bijlsma; Marc G. Besselink; Jan Koster; Wim Timens et al.
Source: check_circle
Crossref

Figure S13 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

2024-06-04 | Preprint
DOI: 10.1158/2326-6066.25964364
Contributors: Michael V. Martin; Salvador Aguilar-Rosas; Katka Franke; Mark Pieterse; Jamie van Langelaar; Renée Schreurs; Maarten F. Bijlsma; Marc G. Besselink; Jan Koster; Wim Timens et al.
Source: check_circle
Crossref

Figure S13 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

2024-06-04 | Preprint
DOI: 10.1158/2326-6066.25964364.v1
Contributors: Michael V. Martin; Salvador Aguilar-Rosas; Katka Franke; Mark Pieterse; Jamie van Langelaar; Renée Schreurs; Maarten F. Bijlsma; Marc G. Besselink; Jan Koster; Wim Timens et al.
Source: check_circle
Crossref

Figure S14 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

2024-06-04 | Preprint
DOI: 10.1158/2326-6066.25964358.v1
Contributors: Michael V. Martin; Salvador Aguilar-Rosas; Katka Franke; Mark Pieterse; Jamie van Langelaar; Renée Schreurs; Maarten F. Bijlsma; Marc G. Besselink; Jan Koster; Wim Timens et al.
Source: check_circle
Crossref

Figure S14 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

2024-06-04 | Preprint
DOI: 10.1158/2326-6066.25964358
Contributors: Michael V. Martin; Salvador Aguilar-Rosas; Katka Franke; Mark Pieterse; Jamie van Langelaar; Renée Schreurs; Maarten F. Bijlsma; Marc G. Besselink; Jan Koster; Wim Timens et al.
Source: check_circle
Crossref

Figure S15 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

2024-06-04 | Preprint
DOI: 10.1158/2326-6066.25964355
Contributors: Michael V. Martin; Salvador Aguilar-Rosas; Katka Franke; Mark Pieterse; Jamie van Langelaar; Renée Schreurs; Maarten F. Bijlsma; Marc G. Besselink; Jan Koster; Wim Timens et al.
Source: check_circle
Crossref

Figure S15 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

2024-06-04 | Preprint
DOI: 10.1158/2326-6066.25964355.v1
Contributors: Michael V. Martin; Salvador Aguilar-Rosas; Katka Franke; Mark Pieterse; Jamie van Langelaar; Renée Schreurs; Maarten F. Bijlsma; Marc G. Besselink; Jan Koster; Wim Timens et al.
Source: check_circle
Crossref

Figure S16 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

2024-06-04 | Preprint
DOI: 10.1158/2326-6066.25964352.v1
Contributors: Michael V. Martin; Salvador Aguilar-Rosas; Katka Franke; Mark Pieterse; Jamie van Langelaar; Renée Schreurs; Maarten F. Bijlsma; Marc G. Besselink; Jan Koster; Wim Timens et al.
Source: check_circle
Crossref

Figure S16 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

2024-06-04 | Preprint
DOI: 10.1158/2326-6066.25964352
Contributors: Michael V. Martin; Salvador Aguilar-Rosas; Katka Franke; Mark Pieterse; Jamie van Langelaar; Renée Schreurs; Maarten F. Bijlsma; Marc G. Besselink; Jan Koster; Wim Timens et al.
Source: check_circle
Crossref

Figure S2 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

2024-06-04 | Preprint
DOI: 10.1158/2326-6066.25964349
Contributors: Michael V. Martin; Salvador Aguilar-Rosas; Katka Franke; Mark Pieterse; Jamie van Langelaar; Renée Schreurs; Maarten F. Bijlsma; Marc G. Besselink; Jan Koster; Wim Timens et al.
Source: check_circle
Crossref

Figure S2 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

2024-06-04 | Preprint
DOI: 10.1158/2326-6066.25964349.v1
Contributors: Michael V. Martin; Salvador Aguilar-Rosas; Katka Franke; Mark Pieterse; Jamie van Langelaar; Renée Schreurs; Maarten F. Bijlsma; Marc G. Besselink; Jan Koster; Wim Timens et al.
Source: check_circle
Crossref

Figure S3 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

2024-06-04 | Preprint
DOI: 10.1158/2326-6066.25964346
Contributors: Michael V. Martin; Salvador Aguilar-Rosas; Katka Franke; Mark Pieterse; Jamie van Langelaar; Renée Schreurs; Maarten F. Bijlsma; Marc G. Besselink; Jan Koster; Wim Timens et al.
Source: check_circle
Crossref

Figure S3 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

2024-06-04 | Preprint
DOI: 10.1158/2326-6066.25964346.v1
Contributors: Michael V. Martin; Salvador Aguilar-Rosas; Katka Franke; Mark Pieterse; Jamie van Langelaar; Renée Schreurs; Maarten F. Bijlsma; Marc G. Besselink; Jan Koster; Wim Timens et al.
Source: check_circle
Crossref

Figure S4 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

2024-06-04 | Preprint
DOI: 10.1158/2326-6066.25964343
Contributors: Michael V. Martin; Salvador Aguilar-Rosas; Katka Franke; Mark Pieterse; Jamie van Langelaar; Renée Schreurs; Maarten F. Bijlsma; Marc G. Besselink; Jan Koster; Wim Timens et al.
Source: check_circle
Crossref

Figure S4 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

2024-06-04 | Preprint
DOI: 10.1158/2326-6066.25964343.v1
Contributors: Michael V. Martin; Salvador Aguilar-Rosas; Katka Franke; Mark Pieterse; Jamie van Langelaar; Renée Schreurs; Maarten F. Bijlsma; Marc G. Besselink; Jan Koster; Wim Timens et al.
Source: check_circle
Crossref

Figure S5 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

2024-06-04 | Preprint
DOI: 10.1158/2326-6066.25964340
Contributors: Michael V. Martin; Salvador Aguilar-Rosas; Katka Franke; Mark Pieterse; Jamie van Langelaar; Renée Schreurs; Maarten F. Bijlsma; Marc G. Besselink; Jan Koster; Wim Timens et al.
Source: check_circle
Crossref

Figure S5 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

2024-06-04 | Preprint
DOI: 10.1158/2326-6066.25964340.v1
Contributors: Michael V. Martin; Salvador Aguilar-Rosas; Katka Franke; Mark Pieterse; Jamie van Langelaar; Renée Schreurs; Maarten F. Bijlsma; Marc G. Besselink; Jan Koster; Wim Timens et al.
Source: check_circle
Crossref

Figure S6 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

2024-06-04 | Preprint
DOI: 10.1158/2326-6066.25964337.v1
Contributors: Michael V. Martin; Salvador Aguilar-Rosas; Katka Franke; Mark Pieterse; Jamie van Langelaar; Renée Schreurs; Maarten F. Bijlsma; Marc G. Besselink; Jan Koster; Wim Timens et al.
Source: check_circle
Crossref

Figure S6 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

2024-06-04 | Preprint
DOI: 10.1158/2326-6066.25964337
Contributors: Michael V. Martin; Salvador Aguilar-Rosas; Katka Franke; Mark Pieterse; Jamie van Langelaar; Renée Schreurs; Maarten F. Bijlsma; Marc G. Besselink; Jan Koster; Wim Timens et al.
Source: check_circle
Crossref

Figure S7 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

2024-06-04 | Preprint
DOI: 10.1158/2326-6066.25964331
Contributors: Michael V. Martin; Salvador Aguilar-Rosas; Katka Franke; Mark Pieterse; Jamie van Langelaar; Renée Schreurs; Maarten F. Bijlsma; Marc G. Besselink; Jan Koster; Wim Timens et al.
Source: check_circle
Crossref

Figure S7 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

2024-06-04 | Preprint
DOI: 10.1158/2326-6066.25964331.v1
Contributors: Michael V. Martin; Salvador Aguilar-Rosas; Katka Franke; Mark Pieterse; Jamie van Langelaar; Renée Schreurs; Maarten F. Bijlsma; Marc G. Besselink; Jan Koster; Wim Timens et al.
Source: check_circle
Crossref

Figure S8 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

2024-06-04 | Preprint
DOI: 10.1158/2326-6066.25964328.v1
Contributors: Michael V. Martin; Salvador Aguilar-Rosas; Katka Franke; Mark Pieterse; Jamie van Langelaar; Renée Schreurs; Maarten F. Bijlsma; Marc G. Besselink; Jan Koster; Wim Timens et al.
Source: check_circle
Crossref

Figure S8 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

2024-06-04 | Preprint
DOI: 10.1158/2326-6066.25964328
Contributors: Michael V. Martin; Salvador Aguilar-Rosas; Katka Franke; Mark Pieterse; Jamie van Langelaar; Renée Schreurs; Maarten F. Bijlsma; Marc G. Besselink; Jan Koster; Wim Timens et al.
Source: check_circle
Crossref

Figure S9 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

2024-06-04 | Preprint
DOI: 10.1158/2326-6066.25964325
Contributors: Michael V. Martin; Salvador Aguilar-Rosas; Katka Franke; Mark Pieterse; Jamie van Langelaar; Renée Schreurs; Maarten F. Bijlsma; Marc G. Besselink; Jan Koster; Wim Timens et al.
Source: check_circle
Crossref

Figure S9 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

2024-06-04 | Preprint
DOI: 10.1158/2326-6066.25964325.v1
Contributors: Michael V. Martin; Salvador Aguilar-Rosas; Katka Franke; Mark Pieterse; Jamie van Langelaar; Renée Schreurs; Maarten F. Bijlsma; Marc G. Besselink; Jan Koster; Wim Timens et al.
Source: check_circle
Crossref

Supplementary Tables S1-S12 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

2024-06-04 | Preprint
DOI: 10.1158/2326-6066.25964322.v1
Contributors: Michael V. Martin; Salvador Aguilar-Rosas; Katka Franke; Mark Pieterse; Jamie van Langelaar; Renée Schreurs; Maarten F. Bijlsma; Marc G. Besselink; Jan Koster; Wim Timens et al.
Source: check_circle
Crossref

Supplementary Tables S1-S12 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

2024-06-04 | Preprint
DOI: 10.1158/2326-6066.25964322
Contributors: Michael V. Martin; Salvador Aguilar-Rosas; Katka Franke; Mark Pieterse; Jamie van Langelaar; Renée Schreurs; Maarten F. Bijlsma; Marc G. Besselink; Jan Koster; Wim Timens et al.
Source: check_circle
Crossref

The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

Cancer Immunology Research
2024-06-04 | Journal article
DOI: 10.1158/2326-6066.CIR-23-0158
Contributors: Michael V. Martin; Salvador Aguilar-Rosas; Katka Franke; Mark Pieterse; Jamie van Langelaar; Renée Schreurs; Maarten F. Bijlsma; Marc G. Besselink; Jan Koster; Wim Timens et al.
Source: check_circle
Crossref

The association of Epstein‐Barr virus infection with CXCR3+ B‐cell development in multiple sclerosis: impact of immunotherapies

European Journal of Immunology
2021-03 | Journal article
DOI: 10.1002/eji.202048739
Contributors: Jamie van Langelaar; Annet F. Wierenga‐Wolf; Johnny P.A. Samijn; Caroline J.M. Luijks; Theodora A. Siepman; Pieter A. van Doorn; Andrew Bell; Menno C. van Zelm; Joost Smolders; Marvin M. van Luijn
Source: check_circle
Crossref

Brain-homing CD4 + T cells display glucocorticoid-resistant features in MS

Neurology Neuroimmunology & Neuroinflammation
2020-11 | Journal article
DOI: 10.1212/NXI.0000000000000894
Contributors: Steven C. Koetzier; Jamie van Langelaar; Katelijn M. Blok; Thierry P.P. van den Bosch; Annet F. Wierenga-Wolf; Marie-José Melief; Kim Pol; Theodora A. Siepman; Georges M.G.M. Verjans; Joost Smolders et al.
Source: check_circle
Crossref

Induction of brain‐infiltrating T‐bet–expressing B cells in multiple sclerosis

Annals of Neurology
2019-08 | Journal article
DOI: 10.1002/ana.25508
Contributors: Jamie van Langelaar; Liza Rijvers; Malou Janssen; Annet F. Wierenga‐Wolf; Marie‐José Melief; Theodora A. Siepman; Helga E. de Vries; Peter‐Paul A. Unger; S. Marieke van Ham; Rogier Q. Hintzen et al.
Source: check_circle
Crossref

T helper 17.1 cells associate with multiple sclerosis disease activity: Perspectives for early intervention

Brain
2018 | Journal article
DOI: 10.1093/brain/awy069
EID:

2-s2.0-85047061963
Contributors: Van Langelaar, J.; Van Der Vuurst De Vries, R.M.; Janssen, M.; Wierenga-Wolf, A.F.; Spilt, I.M.; Siepman, T.A.; Dankers, W.; Verjans, G.M.G.M.; De Vries, H.E.; Lubberts, E. et al.
Source: Self-asserted source
Jamie van Langelaar via Scopus - Elsevier

The macrophage migration inhibitory factor pathway in human B cells is tightly controlled and dysregulated in multiple sclerosis

European Journal of Immunology
2018 | Journal article
DOI: 10.1002/eji.201847623
EID:

2-s2.0-85053811505
Contributors: Rijvers, L.; Melief, M.-J.; van der Vuurst de Vries, R.M.; Stéphant, M.; van Langelaar, J.; Wierenga-Wolf, A.F.; Hogervorst, J.M.; Geurts-Moespot, A.J.; Sweep, F.C.G.J.; Hintzen, R.Q. et al.
Source: Self-asserted source
Jamie van Langelaar via Scopus - Elsevier
How many people are using ORCID?